Family planning. Contraceptive management
Conditions
Interventions
Intervention 1: Longel (levonorgestrel 0.75 mg: Iran hormon Company:two tab(1.5 mg) single dose. Intervention 2: Longel (levonorgestrel 0.75 mg) Iran hormon Company:one tab (0.75 mg) given twice,
Treatment - Drugs
Longel (levonorgestrel 0.75 mg: Iran hormon Company:two tab(1.5 mg) single dose
Longel (levonorgestrel 0.75 mg) Iran hormon Company:one tab (0.75 mg) given twice, 12 hours apart
OCP Ovacept (LD:30microgr ethinylestradiol +15mg levonorgestrel:Aburahan Company :four tab each given twice, 12 hours apart)
Sponsors
Shahid Sadougi Universiy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
16 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: present within 120 hours of unprotected intercourse; regular menstrual cycles and no current use of hormonal contraception Exclusion Criteria: One or more acts of unprotected intercourse more than 120 hours
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unwanted pregnancy. Timepoint: Three week after unprotect intercourse. Method of measurement: Beta HCG titer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstural pattern in next month. Timepoint: Next month. Method of measurement: Using check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahshid Bokie
Shahid Sadougi University of Medical Sciences
Outcome results
None listed